Navigation Links
Low-Carb Diet May Slow Prostate Tumor Growth
Date:11/13/2007

Mouse study could have implications for humans, researchers say

TUESDAY, Nov. 13 (HealthDay News) -- In mice, a low-carbohydrate diet slowed prostate tumor growth, possibly because fewer carbohydrates leads to a drop in insulin production, U.S. researchers say.

"This study showed that cutting carbohydrates may slow tumor growth, at least in mice. If this is ultimately confirmed in human clinical trials, it has huge implications for prostate cancer therapy through something that all of us can controls, our diets," lead researcher Dr. Stephen Freedland, a urologist at Duke University Medical Center, said in a prepared statement.

Previous studies linked insulin and a related substance called insulin-like growth factor (IGF) with the growth of prostate tumors in mice. Freedland and his colleagues theorized that reducing levels of these substances might slow prostate tumor growth.

They compared tumor growth in mice eating either a low-carbohydrate diet; a low-fat but high-carbohydrate diet; or a Western diet high in fat and carbohydrates.

Mice fed the low-carbohydrate diet had the smallest tumor size and longest survival, the team found.

""Low-fat mice had shorter survival and large tumors , while mice on the Western diet had the worst survival and biggest tumors. In addition, though both the low-carb and low-fat mice had lower levels of insulin, only the low-carb mice had lower levels of the form of IGF capable of stimulating tumor growth," Freedland said.

The study is published in the Nov. 13 online edition of the journal Prostate.

Freedland is currently organizing a clinical trial to examine the impact of a low-carbohydrate diet on prostate tumor growth in men.

More information

The American Cancer Society has more about prostate cancer.

'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. A low-carb diet may stunt prostate tumor growth
2. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
3. First biomarker discovered that predicts prostate cancer outcome
4. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
5. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
6. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
7. Red wine compound shown to prevent prostate cancer
8. Barbershop Talks Cut Black Mens Prostate Cancer Risk
9. Generic prostate drug helps find high-risk cancers early
10. Finasteride unlikely to induce high grade prostate cancers
11. Shrinkage of prostate led to overestimation of cancer risk in trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...EINE, France, Nov. 27 Team Garmin-...g team dedicated to ethical sporting and developin...ced today that it will become Team Garmin-Transiti...new sponsor of the team. Transitions Optical is th..., offering the most advanced photochromic technolo...
(Date:11/27/2009)... SEATTLE, Nov. 27 Allrecipes.com ... Thanksgiving traffic numbers, with more than 2.8 ...iding a clear picture of what was served on the bi...giving meal in 2009 weighed in at 2,225 calories p...feast. According to the Allrecipes site, Sweet Po...
(Date:11/26/2009)...27 With cold and flu season upon u...actices to control the spread of infections and av...ly to keep ourselves healthy, but to avoid transmi... RN, MS, CIC (certified in infection-control), nur...al health at Hospital for Special Surgery (HSS) in...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...nnis & Ennis, P.A. is offering free nationwide...asmin birth control pills who have suffered a Deep..., Heart Attack or other related cardiac issues or ... free at 1-800-856-6405 or go to the firm’s ...an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...s using assisted reproductive technology should be...Y, May 20 (HealthDay News) -- Compared to naturall...d reproductive technology (ART) are more likely to...n in Western Australia between 1994 and 2000. , "W...
...NGSTON, N.J., May 21 Milestone Scientific Inc. (O... advanced injection technologies, today announced ...heduled to be held on Thursday, June 4, 2009 begin... Brown, Rudnick, Berlack and Israels located at 7 ...
...VEGAS, May 21 CPC of America, Inc. (OTC Bulletin ... first patent of a synthetic sealant for specific ...ed on the development and testing of the MedClose(...C is focused on the development of its own synthet...
...TON, May 21 Stem Cell Innovations, (Pink Sheets: ...he only products on the market using a standardize...cities associated with nutraceuticals and dietary ...ing system could help prevent recalls associated w...
...Athletes Use Energy Muse Jewelry As Their Lucky Ch...t the skip in their step and the twinkle in their ...wn Johnson and partner Mark Ballas on Season 8 fin...ity -- during the last two weeks of the competitio...
...nts Optimize Resources With Imaging, Behavioral an... Delivering efficient, high-quality healthcare is...ality and workflow tools embedded in the new Mill...delines, workflow by mapping its clinical content...
Other Medicine News:Health News:Fertility Treatment Twins More at Risk for Hospitalizations 2Health News:Milestone Scientific to Host 2009 Annual Meeting of Stockholders on Thursday, June 4, 2009 in New York City 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 3Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 2Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 3Health News:Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry 2Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 2Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 3
(Date:11/26/2009)...HANNESBURG, South Africa, Nov. 26 ... of the Year Award in the Generic Pharmaceutical M...mited. ,, (Logo: http://www.newscom.com/cgi-bi...the Year Award, the following criteria were used t... competitors: growth strategy and implementation, ...
(Date:11/25/2009)...ETON, N.J., Nov. 25 Phar...armaceutical company committed to discovering, dev...iral infections, reported financial results for th...er 30, 2009 Pharmasset held $58.4 million in cash,..., Pipeline Update and 2009 Highlights ,, RG...
(Date:11/25/2009)... PALM BEACH, Fla., Nov. 25 /PRNewswire-FirstCall/ ...ericans, especially the 27 million living with unt... that happy, says audiologist Cindy Beyer. ,, D... EAR ), one of America,s largest hearing care and ... hearing loss to stress, frustration, and social i...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 1Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 2Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 3QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 1QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 2QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 3QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 4QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 5QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 6AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 1AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 2AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 3AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 4AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 5
...ation aimed at enabling vaccine production facilit...itional egg-based facility., * Once established, ...of, pandemic flu vaccine to commence within 12 we...ngland and ROCKVILLE, Md., Dec. 10, GE Healthcare,...and Novavax Inc. (Nasdaq: NVAX ), today announced...
...ec. 10 Exelixis, Inc. (Nasdaq:,EXEL), today repor...XL019,in patients with myelofibrosis, a myeloproli...al small molecule that selectively inhibits the ty... activated in response to,cytokines and hematopoie...ted in the majority of MPD patients and is deregul...
Other Medicine Technology:GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 2GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 3GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 4Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 2Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 3Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 4
PAP Microwell ELISA
...EG-9200 is a Windows 2000 PC based EEG with high p...e and software. EEG-9200 provides high quality per... in the sleep lab or EEG lab. Quality EEG recordin...ICU. Neurofax has high performance, high sensitivi...
...pact is the first magnetic stimulator to offer the...c stimulation. It is designed to provide the simpl...stic routine (at the same time, it may also help r...ions without moving away from your patient). , ,...
Fidelity IAB Intra-Aortic Balloon Catheter
Medicine Products: